27
Harvar d Medica l School Harvar d Medica l School Hypertensive Heart Disease Gene Bukhman January 12 th , 2005

0105 GBukhman Hypertensive Heart Disease.ppt

Embed Size (px)

Citation preview

Harvard Medical SchoolHarvard Medical SchoolHypertensive Heart DiseaseGene BukhmanJanuary 12th, 2005Harvard Medical SchoolEpidemiology INumber of Patients with Hypertension in the Unite !tates" 50 mi##ionNumber of Patients with Heart $ai#ure" 5 mi##ionPer%ent of Heart $ai#ure Patients with Hypertension" &5'JNC 7. 2004Jessup and Brozena. NEJ. 200!Harvard Medical Schoolosterd et al. NEJ. "##7Harvard Medical Schoolortality in Hypertension50' from is%hemi% heart isease or heart fai#ure((' from %erebro)as%u#ar isease10 to 15' from rena# fai#ure$aplan in %ipes& 'i((y& Bono)& and Braun)ald. 200*Harvard Medical SchoolHypertensive Heart Disease*oronary +rtery ,iseaseHeart $ai#ure- ,iasto#i% ,ysfun%tion .mpaire re#a/ation 0eft )entri%u#ar myo%yte hypertrophy .nterstitia# fibrosis- !ysto#i% ,ysfun%tion .s%hemi% %ariomyopathy 0ate %onse1uen%e of after#oa+rrhythmias- +tria# fibri##ation 0eft atria# en#ar2ement- 3entri%u#ar +rrythmias$aplan in %ipes& 'i((y& Bono)& and Braun)ald. 200*Harvard Medical School'e+t ,entri-ular Hypertrop.y I*on%entri% in%rease in 03 mass*ompensatory response to in%rease after#oa*o##a2en4yo%yte hypertrophy'orell and Cara(ello. Cir-ulation. 2000Harvard Medical School'e+t ,entri-ular Hypertrop.y II5ffe%t of me%hani%a# #oain2 most %#ear in rapi re2ression fo##owin2 aorti% )a#)e rep#a%ement.n systemi% hypertension %onfoune by ro#e of an2iotensin .. an sympatheti% hormones03H often e)e#ops after other si2ns of iasto#i% ysfun%tion in H6N03H a#so seen to pre%ee e)e#opment of systemi% H6N'orell and Cara(ello. Cir-ulation. 2000Harvard Medical SchoolJessup and Brozena. NEJ. 200!Harvard Medical SchoolConse/uen-es o+ ',H +#thou2h initia##y %ompensatory, 03H u#timate#y asso%iate with risk of %ario)as%u#ar e)ents simi#ar to history of prior myo%aria# infar%tion .s%hemia- ,e%rease %oronary reser)e with in%rease 03 mass an2ina- Greater risk of eath fo##owin2 myo%aria# infar%tion Heart $ai#ure- ,epresse 03 systo#i% an iasto#i% fun%tion +rrhythmia- +tria# fibri##ation- 3entri%u#ar arrhythmias Nonuniform a%tion potentia# pro#on2ation +#tere repo#ari7ation !pe%ifi% )u#nerabi#ity to torsaes .s%hemi% )entri%u#ar arrhythmiaDunn and 0+e++er. NEJ. "###Harvard Medical SchoolE-.o-ardiograp.y 1indings in 2ystemi- H3N0eft atria# en#ar2ement4itra# annu#ar %a#%ifi%ation- 4i# to moerate mitra# re2ur2itation+orti% root i#atation+orti% )a#)e s%#erosis- 4i# aorti% re2ur2itation,iasto#i% ysfun%tion-.mpaire re#a/ation-8estri%ti)e pattern8eu%e e9e%tion fra%tion- Usua##y #ate %onse1uen%e with )entri%u#ar i#atation!ymmetri% #eft )entri%u#ar hypertrophy4tto. 2000Harvard Medical School5urigemma and 6aas-.. NEJ. 2004Harvard Medical SchoolDiastoli- Dys+un-tion5urigemma and 6aas-.. NEJ. 20047ed+ield. NEJ. 2004Harvard Medical School0ossi(le 7oleo+ ',H determinationin systemi- H3N1: !e#e%tion of patients for treatment2: *hoi%e of treatment a2ent(: 4onitorin2Harvard Medical SchoolE-.o-ardiograp.i-evaluation o+ ',H$ramin2ham as e%ho%ario2raphy in 1;&;5*G probab#y has 10 years o#Present in 20 to (0 per%ent of otherwise #ow risk patients with H6N'orell and Cara(ello. Cir-ulation. 2000Harvard Medical Schoolultiple met.ods o+ e-.o-ardiograp.i- le+t ventri-ular mass -al-ulation034 ? 0:= / @1:0> / A03., B 03PC6 B .3!6D( -03.,(E0imits set by 2 stanar e)iations of the $ramin2ham %ohort meanPoor reprou%ibi#ityPossib#e a)anta2e of %aria% 48 A4annin2 200>D'orell and Cara(ello. Cir-ulation. 2000Harvard Medical School3reatment o+ Hypertension and 5(solute Cardiovas-ular 7is8Benefit of treatment proportiona# to o)era## %ario)as%u#ar risk8isk in%reases with #e)e# of b#oo pressure without %#ear thresho#a-a.on. NEJ. 2000Harvard Medical School',H and treatment o+ H3N8e2ression of 03H with treatment by a## %#asses of a2ents e/%ept ire%t )asoi#atorsPossib#e superiority of a%e inhibitors an an2iotensin re%eptor b#o%kersNot %#ear if benefit to 03H re2ression inepenent from o)era## benefit of b#oo pressure reu%tionHarvard Medical School'osartan Intervention +or endpoint redu-tion 9'I1E: trialDa.lo+ et al. 'an-et. 2002Harvard Medical School5CC;5H5;52E 200! 6uidelinesdire-ted e-.o-ardiogram may (e indi-ated +or t.is purpose.C.eitlin et al. 5CC;5H5;52E. 200!Harvard Medical School5CC;5H5;52E 200! 6uidelines